Natural Orifice Specimen Extraction Surgery (NOSES) is an innovative advancement in minimally invasive surgical techniques, offering the advantage of avoiding abdominal wall incisions for specimen extraction. This approach integrates the benefits of laparoscopic or robotic surgery with specimen extraction through natural orifices, thereby reducing surgical trauma, minimizing postoperative pain, and facilitating faster recovery1.
Robot-assisted surgery has revolutionized the field of minimally invasive procedures by enhancing precision, dexterity, and visualization through robotic systems2. The integration of surgical robotics further optimizes surgical outcomes by enabling more intricate dissection and suturing, particularly in anatomically challenging areas such as the narrow pelvis3. Notably, robotic-assisted surgery is associated with a reduced risk of conversion to open surgery in obese and morbidly obese patients compared to conventional laparoscopic approaches4.
Robot-assisted NOSES is emerging as a feasible and safe alternative to conventional laparoscopic or open surgery for colorectal cancer treatment. By eliminating the need for auxiliary incisions for specimen extraction, NOSES can potentially reduce postoperative complications, shorten hospital stays, and enhance cosmetic outcomes without compromising oncological safety5. This protocol herein presents a surgical approach involving robot-assisted transanal specimen extraction radical sigmoidectomy without an auxiliary abdominal incision (NOSES-IV).
Structural design of the robot
The Surgical Robot system consists of a surgeon control console, a three-arm patient cart, and a vision cart (Figure 1). The surgeon console is an open-vision system equipped with a foot clutch for switching between systems. The patient cart features two surgical arms and a camera arm. For safety, the system automatically locks the robotic arms of the patient cart when the sensor on the main manipulator detects that the hand has disengaged from the device. An additional trocar is also placed for the assistant. The visual cart is employed by the assistant surgeon to observe the surgical field. During the operation, the surgeon sits at the open surgeon's console with an upright neck posture, while the three-arm patient cart is positioned on the patient's left side.
CASE PRESENTATION:
The patient underwent endoscopic submucosal dissection (ESD) following the identification of a polypoid lesion in the sigmoid colon during a colonoscopy, which had been noted 1 month prior to admission. Postoperative histopathological examination revealed a laterally spreading tumor in the sigmoid colon with malignant transformation, classified as moderately differentiated adenocarcinoma. The tumor measured 0.8 cm in total diameter, with the cancerous component occupying 0.6 cm. Histological examination confirmed submucosal invasion, with an infiltration depth exceeding 1,000 µm, necessitating additional surgical intervention.
The patient's medical history included hypertension, diabetes, and brain infarction. The patient, aged 67, had a body mass index (BMI) of 25.7 and showed no signs of anemia. Physical examination revealed no enlargement of the superficial lymph nodes, and abdominal assessment showed no abnormal findings. Additionally, digital rectal examination revealed no masses.
Accessory examinations were conducted, revealing no significant abnormalities in blood routine analysis, biochemical profiling, blood coagulation, or CA19-9 levels (32.13 U/mL). However, CEA (7.07 ng/mL) was elevated. Consequently, a multidisciplinary team decided to proceed with robot-assisted NOSES.
Indications and contraindications of NOSES IV:
Indications
The tumor is located in the upper rectum, rectosigmoid colon, and distal sigmoid colon; the circumferential diameter of the tumor should be <3 cm; and the tumor should not invade the serosa.
Contraindications
A large tumor that poses a challenge to extract a specimen from the anus; the mesorectum is too thick to be extracted from the anus; and body habitus (BMI > 35 kg/m2).